34 - Immunopharmacology Flashcards

1
Q

Why use immunosuppressants?

A

1) suppression of rejection of transplanted organs and tissues

2) suppression of graft vs host (donor immune cells reacting against host)

3) autoimmune disease: lupus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is rheumatoid arthritis

A

autoimmune disease primarily affecting the joints

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Lupus?

A

multi organ autoimmune disease (characteristic rash)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Adaptive immunity: induction phase

A

recognition and presentation of foreign antigen by an antigen presenting cell

activation and proliferation of naive T helper cells (Th0) into differentiates Th1 and Th2 cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Adaptive immunity: effector phase

A

cell mediated T cell responses derived from Th1 cells

antibody-mediated responses from B cells derived from Th2 cells

Both processes lead to immune cells killing infected or foreign cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Key drug targets in immune response

A

inhibition of IL-2 production/action

inhibition of cytokine gene expression

cytotoxicity

inhibition of nucleic acid synthesis

blockage of various T cell surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Calcineurin inhibitors

A

eg cyclosporin and tacrolimus

activation of naive Th0 cells and clonal expansion of T cells require the cytokine IL-2

IL-2 production controlled by intracellular signaling cascades, including calcineurin-nuclear factor of activated T-Cells (NFAT) pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is cyclosporin and what does it do?

A

calcineurin inhibitor

inhibit calcinerin by the cyclophilin:cyclosporine complex

prevents NFAT mediated gene transcription of IL-2, leading to inhibition of T-cell maturation and proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is tacrolimus and what does it do?

A

Calcineurin inhibitor

inhibit calcinerin by the FKBP: tacrolimus complex

NFAT mediated gene transcription of IL-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Rapamycin?

A

Proliferation Signal Inhibitors

Interfere with the downstream signals of IL2 receptor activation

rapamycin binds to FKBP (same target as tacrolimus)

inhibits mTOR (pathway for cell growth and proliferation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What do FKPs and cyclophilins do?

A

immunophilins, help cytokines fold to right shape

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is cyclophosphamide?

A

cytotoxic agent, leads to cross link of neighbouring DNA base, useful for suppression of rapidly dividing immune cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is azathioprine?

A

metabolized to 6 mercaptopurine, inhibit nucleotide synth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Monoclonal antibodies have

A

2 light chains 2 heavy chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fab region of antibodies

A

The structure of the antibody can also be portioned into two antigen binding fragments (Fab) and the crystallizable fragment (Fc)

The Fab region determines antigen specificity

The Fc region determines the antibody ‘class’ (IgA, IgG, IgM, etc). Different classes of Fc regions are recognized by receptors on different immune cell types, leading to different immune responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Alemtuzumab?

A

huamnized IgG1 that recognizes CD52 found on many immune cell types, including T and B ells

IgG1 Fc domain is recognized by phagocytic immune cells, complement, and NK cells

leads to immune-mediated destruction of otherwise healthy and B cells

17
Q

What is Basiliximab?

A

chimeric mouse-human IgG1 that binds to CD25, part of the IL2 receptor on activated T cells

causes immunosuppression by blocking IL2 from binding to activated T cells